Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -11.07x is 26% below its 5-year average of -8.77x, near the high end of its 5-year range (-30.01x–-5.23x).
27.19% below its 12-month average of -8.70x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.65x.
INTEREST COVERAGE RATIO
-11.07x
INTEREST COVERAGE RATIO AVG TTM
-8.70x
INTEREST COVERAGE RATIO AVG 3Y
-10.92x
INTEREST COVERAGE RATIO AVG 5Y
-8.77x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.19%
CURRENT VS 3Y AVG
-1.34%
CURRENT VS 5Y AVG
-26.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.85x
median of 397 covered companies
CURRENT VS SECTOR MEDIAN
-128.25%
vs the sector median at left
Inhibrx Biosciences Inc.
Market Cap
$1.38B
Interest Coverage Ratio
-11.07x
TTM Avg
-8.70x
3Y Avg
-10.92x
5Y Avg
-8.77x
Market Cap
$1.41B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.43B
Interest Coverage Ratio
0.60x
TTM Avg
0.60x
3Y Avg
0.60x
5Y Avg
0.60x
Market Cap
$1.43B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.32B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.31B
Interest Coverage Ratio
-100.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
Interest Coverage Ratio
30.72x
TTM Avg
19.49x
3Y Avg
15.15x
5Y Avg
21.38x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibrx Biosciences Inc. (INBX) | $1.38B | -11.07x | -8.70x | -10.92x | -8.77x |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | N/A | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.34B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 0.60x | 0.60x | 0.60x | 0.60x |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.32B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | -100.93x | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 30.72x | 19.49x | 15.15x | 21.38x |
| GH Research PLC (GHRS)vs › | $1.46B | -131.05x | N/A | N/A | N/A |
Interest Coverage
-11.1x
Debt/Equity
N/A
Current Ratio
5.07
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.65x |
| 2026-03-31 | -8.81x |
| 2025-12-31 | -9.71x |
| 2025-09-30 | -10.63x |
| 2025-06-30 | -8.72x |
| 2025-03-31 | -15.95x |
| 2024-06-30 | -30.01x |
| 2024-03-31 | -9.08x |
| 2023-12-31 | -10.74x |
| 2023-09-30 | -5.62x |
| 2023-06-30 | -5.23x |
| 2023-03-31 | -8.62x |
| 2022-12-31 | -6.64x |
| 2022-09-30 | -5.62x |
| 2022-06-30 | -10.99x |
| 2022-03-31 | -12.77x |
| 2021-12-31 | -10.92x |
| 2021-09-30 | -10.57x |
| 2021-06-30 | -21.66x |
| 2021-03-31 | -24.91x |
| 2020-12-31 | -32.16x |
| 2020-09-30 | -3.51x |
| 2020-06-30 | -5.04x |
| 2020-03-31 | -7.19x |
| 2019-12-31 | -5.92x |
| 2019-09-30 | -4.89x |
| 2019-06-30 | -21.63x |
| 2019-03-31 | -14.62x |
| 2018-06-30 | -17.20x |
| 2018-03-31 | -19.73x |
